BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27185371)

  • 1. Depletion of FOXM1 via MET Targeting Underlies Establishment of a DNA Damage-Induced Senescence Program in Gastric Cancer.
    Francica P; Nisa L; Aebersold DM; Langer R; Bladt F; Blaukat A; Stroka D; Martínez MR; Zimmer Y; Medová M
    Clin Cancer Res; 2016 Nov; 22(21):5322-5336. PubMed ID: 27185371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.
    Cui J; Xia T; Xie D; Gao Y; Jia Z; Wei D; Wang L; Huang S; Quan M; Xie K
    Oncogene; 2016 Sep; 35(36):4708-18. PubMed ID: 26876216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Src impairs the growth of met-addicted gastric tumors.
    Bertotti A; Bracco C; Girolami F; Torti D; Gastaldi S; Galimi F; Medico E; Elvin P; Comoglio PM; Trusolino L
    Clin Cancer Res; 2010 Aug; 16(15):3933-43. PubMed ID: 20628031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification.
    Okamoto W; Okamoto I; Arao T; Kuwata K; Hatashita E; Yamaguchi H; Sakai K; Yanagihara K; Nishio K; Nakagawa K
    Mol Cancer Ther; 2012 Jul; 11(7):1557-64. PubMed ID: 22729845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer.
    Della Corte CM; Bellevicine C; Vicidomini G; Vitagliano D; Malapelle U; Accardo M; Fabozzi A; Fiorelli A; Fasano M; Papaccio F; Martinelli E; Troiani T; Troncone G; Santini M; Bianco R; Ciardiello F; Morgillo F
    Clin Cancer Res; 2015 Oct; 21(20):4686-97. PubMed ID: 26124204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Positive Feedback Loop of lncRNA-
    Xu MD; Wang Y; Weng W; Wei P; Qi P; Zhang Q; Tan C; Ni SJ; Dong L; Yang Y; Lin W; Xu Q; Huang D; Huang Z; Ma Y; Zhang W; Sheng W; Du X
    Clin Cancer Res; 2017 Apr; 23(8):2071-2080. PubMed ID: 27756785
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade.
    Jin H; Park MH; Kim SM
    Oncol Rep; 2015 Apr; 33(4):2031-6. PubMed ID: 25633416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor.
    Shibui Y; Kohashi K; Tamaki A; Kinoshita I; Yamada Y; Yamamoto H; Taguchi T; Oda Y
    J Cancer Res Clin Oncol; 2021 May; 147(5):1499-1518. PubMed ID: 33221995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells.
    Park CH; Cho SY; Ha JD; Jung H; Kim HR; Lee CO; Jang IY; Chae CH; Lee HK; Choi SU
    BMC Cancer; 2016 Jan; 16():35. PubMed ID: 26801760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cells.
    Hu CJ; Wang B; Tang B; Chen BJ; Xiao YF; Qin Y; Yong X; Luo G; Zhang JW; Zhang D; Li S; He F; Yang SM
    Biochim Biophys Acta; 2015 Mar; 1849(3):290-9. PubMed ID: 25482013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1.
    Zeng J; Wang L; Li Q; Li W; Björkholm M; Jia J; Xu D
    J Pathol; 2009 Aug; 218(4):419-27. PubMed ID: 19235838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of B-Raf
    Choi YW; Nam GE; Kim YH; Yoon JE; Park JH; Kim JH; Kang SY; Park TJ
    Biochem Biophys Res Commun; 2019 Aug; 516(3):866-871. PubMed ID: 31270027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance.
    Khongkow P; Karunarathna U; Khongkow M; Gong C; Gomes AR; Yagüe E; Monteiro LJ; Kongsema M; Zona S; Man EP; Tsang JW; Coombes RC; Wu KJ; Khoo US; Medema RH; Freire R; Lam EW
    Oncogene; 2014 Aug; 33(32):4144-55. PubMed ID: 24141789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of the FoxM1 enhances the sensitivity of gastric cancer cells to cisplatin by targeting Mcl-1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Bao-Hongluan ; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Jun; 71(6):345-8. PubMed ID: 27455555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations.
    Peng S; Sen B; Mazumdar T; Byers LA; Diao L; Wang J; Tong P; Giri U; Heymach JV; Kadara HN; Johnson FM
    Oncotarget; 2016 Jan; 7(1):565-79. PubMed ID: 26623721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis.
    Wang Y; Zeng J; Pan J; Geng X; Li L; Wu J; Song P; Wang Y; Liu J; Wang L
    Oncotarget; 2016 May; 7(20):29275-86. PubMed ID: 27086911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors.
    Cepero V; Sierra JR; Corso S; Ghiso E; Casorzo L; Perera T; Comoglio PM; Giordano S
    Cancer Res; 2010 Oct; 70(19):7580-90. PubMed ID: 20841479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1.
    Wu J; Qin W; Wang Y; Sadik A; Liu J; Wang Y; Song P; Wang X; Sun K; Zeng J; Wang L
    J Cell Biochem; 2018 Nov; 119(11):9042-9054. PubMed ID: 30076647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.